Cautious. ERF.PA's 50/100 verdict reflects balanced but uncompelling fundamentals without standout growth or profitability metrics to justify conviction. Leadership Alignment scores middling (50/100), suggesting misaligned incentives or modest insider commitment, limiting confidence in capital allocation discipline. With Vulnerability Profile unassessed, structural risks remain opaque—warranting patience for clearer catalysts or margin improvement before commitment.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for EUROFINS SCIENT.:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 50/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates EUROFINS SCIENT. (ERF.PA) at 50/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. ERF.PA's 50/100 verdict reflects balanced but uncompelling fundamentals without standout growth or profitability metrics to justify conviction. Leadership Alignment scores middling (50/100), suggesting misaligned incentives or
ERF.PA's current Stocky Verdict is 50/100, placing it in the "Cautious" band. This composite combines a 50/100 Compounder score, 50/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for EUROFINS SCIENT. yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
EUROFINS SCIENT. scores 50/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
Vulnerability Profile for EUROFINS SCIENT. covers customer concentration, supply chain risk, refinancing walls, and regulatory exposure. Not yet finalised.
Sign up free and unlock the full analysis on ERF.PA — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
Or jump straight to the interactive dashboard for ERF.PA in the app.
